Swiss pharmaceutical group Roche suspends new investments in Germany, division head says
Daniel Steiners noted that the move was driven by stringent austerity measures introduced by the German government in the healthcare sector
5News собрал это резюме из публичной ленты источника. Полная статья со всеми подробностями находится на tass.com — права на контент принадлежат TASS (oficial, inglês).